Pharmacology V (1 hr Lecture)

Description

This course deals with the characteristics and use of drugs intended for the treatment of bronchial asthma, chronic obstructive pulmonary disease, pulmonary hypertension, cystic fibrosis, upper and lower respiratory tract infections, and drug-induced respiratory problems. In addition to neurological disorders including (epilepsy, Parkinson’s disease, ..etc). The mechanism of action of different agents commonly used for the aforementioned disorders is provided. Interactive approaches are used to familiarize the students with background information underlying the expected side effects and the interactions between these agents and other drugs, foods, or disease conditions.

Program

Bachelor of Pharmacy - PharmD (Clinical Pharmacy)

Objectives

• 1.1	Recognize the drug groups used to treat respiratory and neurological disorders
  1.2	Describe the detailed mechanism of action and the role of drugs in correcting the targeted pathophysiological process.
  1.3	Explain the underlying causes of potential drug toxicities and side effects, as well as potential drug-drug and drug-food interactions.
  2.1	Analyze the role of the drug in correcting the targeted pathophysiological process.
  2.2	Interpret information to avoid and resolve potential side effects and drug-drug interactions.
  2.3	Interpret the role of the drug in correcting the targeted pathophysiological process and the underlying causes of potential drug toxicities
  3.1	Compose proper advice about the ideal use of drugs based on their mechanism of action.
  3.2	Apply problem solving skills in addressing and solving drug-related problems.
  3.3	Relate etiology, epidemiology, pathophysiology, laboratory diagnosis, and clinical features of respiratory and neurological disorders and their pharmacotherapeutics approaches.
  4.1	Acquire ability to handle software including information databases and drug-drug interaction software
  4.2	Ensure timely provision of information to solve drug-related problems
  4.3	Apply critical thinking in recognition of potential drug-related problems
  4.4	Practice independent learning needed for continuous professional development.